Calendar
Top-down
A look at earnings from the view of macro-economists and market technicians
Market Overview
Heat Map
Sentiment
Technicals
Retail Sales
Pricing
Manu-facturing
Economic Cycle
Bottom-up
A bottom-up view of earnings from professional equity analysts
Earnings Highlights
Date Trades
Earnings News
Pivots
Earnings Cycle
Sector Analysis
Investor
Trader
Support
Documentation, research, and support for the information provided
Indicators
Results
About Us
Library
Contact Us
Plays
Score
Grade
Sign In
Sign In
or
Register
Forgot Password?
OR
Sign in using:
Don't have an account?
Register
RGEN
$111.43
Repligen
($2.09)
(1.84%)
RGEN
Earnings Whisper ®
N/A
3rd Quarter September 2025
Consensus: $0.42
Revenue: $179.07 Mil
Tuesday
Oct 28
7:30 AM ET
Score
Grade
Tweet
Share
Watch
Sentiment
Analysts
Sentiment
Analysts
Tweet
Share
Watch
Latest EPS
Tuesday, July 29, 2025
Repligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
What do you expect when RGEN reports earnings?
Beat
Meet
Miss
Where is RGEN's stock price going from here?
Up
Flat
Down
Analysts
Score
Grade
Sentiment
Analysts
Pivots
Resistance
$116.09
$115.04
$113.24
$112.19
Support
$110.39
$109.34
$107.54
Tweet
Trends
Short-term Price
Intermediate-term Price
Long-term Price
Investors' Sentiment
Analysts' Sentiment
Earnings Estimates
Growth
Description
Repligen Corporation is a leading provider of advanced bioprocessing technologies and solutions used by large biopharmaceutical companies and contract manufacturing organizations for manufacturing biologic drugs, such as monoclonal antibodies (mAbs) and gene therapies. Repligen earns revenues from the sale of several products, which can be categorized mainly under three segments, namely Filtration, Chromatography and Protein products. The chromatography products include OPUS and OPUS PD chromatography columns, chromatography resins and ELISA test kits. Filtration products consist of XCell Alternating Tangential Flow (ATF) Systems and consumables, KrosFlo filtration products and SIUS filtration products. Protein products comprise the Protein A ligands and cell culture growth factors.
Peers
Biogen
Amgen
Gilead Sciences
Neurocrine Biosciences
Qiagen N.V.
Bio-Techne
BioCryst Pharmaceuticals
Stem
Novavax
Sangamo Therapeutics
Expectations
›
Repligen